|
Re: 2023 Outlook per MD&A
|
3
|
Resverlogix Corp.
|
Apr 09, 2023 01:24PM
|
|
Re: Consequences of BETonMACE Findings
|
3
|
Resverlogix Corp.
|
May 10, 2016 04:07PM
|
|
Re: Glucose fluctuation
|
3
|
Resverlogix Corp.
|
Jun 15, 2015 02:53PM
|
|
Re: We should get financials this week
|
3
|
Resverlogix Corp.
|
Mar 22, 2021 12:07PM
|
|
Re: Zenith has been quiet.......too quiest
|
3
|
Zenith Epigenetics
|
Jun 06, 2016 06:29PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 29, 2019 03:49PM
|
|
Vote reminder
|
3
|
Resverlogix Corp.
|
Oct 10, 2023 11:14AM
|
|
Re: Zenith has been quiet.......too quiest
|
3
|
Zenith Epigenetics
|
Jun 09, 2016 01:32PM
|
|
Re: Zenith website undergoing changes
|
3
|
Zenith Epigenetics
|
Mar 05, 2016 12:59PM
|
|
Re: Richmond Club clarification please...
|
3
|
Resverlogix Corp.
|
Jun 27, 2015 02:30PM
|
|
Re: Biogen looks to FDA for approval of early Alzheimers drug.
|
3
|
Resverlogix Corp.
|
Oct 22, 2019 11:42AM
|
|
Re: Nothing happening
|
3
|
Resverlogix Corp.
|
Jul 16, 2021 07:04PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Dec 22, 2020 01:32PM
|
|
Re: HDL Functionality
|
3
|
Resverlogix Corp.
|
May 09, 2019 02:47PM
|
|
Re: My conversation with Don....
|
3
|
Resverlogix Corp.
|
Dec 03, 2017 05:16PM
|
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
3
|
Resverlogix Corp.
|
Jun 12, 2020 04:44PM
|
|
Re: Financial Statement Q2, 2023 /MD&A
|
3
|
Resverlogix Corp.
|
Aug 12, 2023 07:07PM
|
|
Re: Amarin CEO interview
|
3
|
Resverlogix Corp.
|
Nov 12, 2018 02:50PM
|
|
Re: Covid China
|
3
|
Resverlogix Corp.
|
Mar 29, 2022 10:06AM
|
|
Re: P3
|
3
|
Resverlogix Corp.
|
Jun 19, 2015 08:08AM
|
